Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px

Organisation › Details

Theragnostics Ltd.

https://www.theragnostics.com

Theragnostics is a private clinical-stage pharmaceutical company developing precision oncology products for diagnostic medical imaging and targeted radionuclide therapy. The Company has completed a number of proof-of-concept phase I and II clinical trials for several radionuclide diagnostics and targeted therapies. *

	Start	2019-09-05 existent
	Group	Ariceum Therapeutics (Group)
	Industry	radionuclide-labelled diagnostic
	Industry 2	RADIOPHARMACEUTICAL (RPT)
	Person	Mullen, Greg (Ariceum Therapeutics 202306– COO before Theragnostics CEO)
	Person 2	Smith, Gareth (ImaginAb 202105– General Manager Europe before Theragnostics)

	Region	Bracknell, Berkshire
	Country	United Kingdom (GB)
	Street	2 Arlington Square
	City	RG12 1WA Bracknell, Berkshire
	Tel	+44-330-606-7437
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Theragnostics Ltd.. (9/5/19). "Press Release: Theragnostics Signs Agreement with AstraZeneca". London.

		Record changed: 2023-07-23

More documents for Ariceum Therapeutics (Group)

[1] Eckert & Ziegler SE. (12/5/24). "Press Release: Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments". Berlin....
[2] Ariceum Therapeutics GmbH. (6/1/23). "Press Release: Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd". Berlin....
[3] Ariceum Therapeutics GmbH. (5/11/23). "Press Release: UCB and Ariceum Therapeutics Sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer". Berlin & Brussels....
[4] Ariceum Therapeutics GmbH. (4/18/23). "Press Release: Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline". Berlin....
[5] Ariceum Therapeutics GmbH. (2/1/23). "Press Release: Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, M.D., as Chief Medical Officer". Berlin....
[6] Ariceum Therapeutics GmbH. (10/27/22). "Press Release: Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership". Berlin & North Augusta, SC....
[7] Ariceum Therapeutics GmbH. (6/8/22). "Press Release: Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers". Berlin....
[8] ImaginAb, Inc.. (5/12/21). "Press Release: ImaginAb, Inc. Forms European Subsidiary and Appoints General Manager-Europe". Los Angeles, CA & San Diego, CA....
[9] Theragnostics Ltd.. (9/5/19). "Press Release: Theragnostics Signs Agreement with AstraZeneca". London....
[10] Theragnostics Ltd.. (2/28/19). "Press Release: Theragnostics Ltd Expands Oncology Portfolio with Licensing of radioPARP Inhibitor"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]